MSCV-myc-CAR-2A-Thy1.1 Citations (2)

Originally described in: NR4A transcription factors limit CAR T cell function in solid tumours.
Chen J, Lopez-Moyado IF, Seo H, Lio CJ, Hempleman LJ, Sekiya T, Yoshimura A, Scott-Browne JP, Rao A Nature. 2019 Mar;567(7749):530-534. doi: 10.1038/s41586-019-0985-x. Epub 2019 Feb 27. PubMed Journal

---

Articles Citing MSCV-myc-CAR-2A-Thy1.1

Articles
TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy. Patel CH, Dong Y, Koleini N, Wang X, Dunkerly-Eyring BL, Wen J, Ranek MJ, Bartle LM, Henderson DB, Sagert J, Kass DA, Powell JD. JCI Insight. 2023 Nov 8;8(21):e167829. doi: 10.1172/jci.insight.167829. PubMed
The Nuclear Receptor NR1B1/RARalpha Arrests the Differentiation of Anti-Tumor Effector Cytotoxic T Cells. Niekamp P, Kim RH, Jayaraman A, Klement N, Kostlan R, Kim CH. Adv Sci (Weinh). 2025 May;12(17):e2410241. doi: 10.1002/advs.202410241. Epub 2025 Mar 11. PubMed

If you have published an article using this material, please email us at to have your article added to this page.